2016
DOI: 10.1186/s12890-016-0183-7
|View full text |Cite
|
Sign up to set email alerts
|

Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report

Abstract: BackgroundPulmonary arterial hypertension (PAH) is a rare, progressive, fatal vascular disorder. Genetic predisposition plays vital roles in the development of PAH, with most mutations being identified in genes involved in the transforming growth factor beta (TGF-β) signaling pathways. Defects in the BMP9 gene have been documented in hereditary hemorrhagic telangiectasia (HHT), the most common inherited vascular disorder, which is occasionally associated with PAH. Selective enhancement of endothelial BMPR2 wit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
83
1
2

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 75 publications
(86 citation statements)
references
References 12 publications
0
83
1
2
Order By: Relevance
“…However, some studies also demonstrated that BMP9 can induce MSCs to differentiate into various cell types [22,65,66]. Moreover, aberrant BMP9 expression might be involved in certain diseases [20,29,34]. These studies suggest that several signaling pathways are involved in BMP9-regulated cell fate or proliferation, but the specific pathways are unclear.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…However, some studies also demonstrated that BMP9 can induce MSCs to differentiate into various cell types [22,65,66]. Moreover, aberrant BMP9 expression might be involved in certain diseases [20,29,34]. These studies suggest that several signaling pathways are involved in BMP9-regulated cell fate or proliferation, but the specific pathways are unclear.…”
Section: Resultsmentioning
confidence: 99%
“…Several metabolic processes are regulated by BMP9, including glucose and lipid metabolism [28,29], iron metabolism [30], endothelial function, and angiogenesis [31,32,33]. Accordingly, abnormal BMP9 expression may be involved in various diseases [29,34,35,36].…”
Section: Introductionmentioning
confidence: 99%
“…Loss-of-function BMPR2 mutations are the major genetic cause for PAH, and of the additional seven mutated genes identified in PAH patients to date, six are involved in the endothelial ALK1/BMPR-II pathway, of which BMP9 and BMP10 are the cognate ligands [18]. In fact, a BMP9 homozygous nonsense mutation was recently reported in a 5-year old paediatric PAH patient [19], which would be predicted to lead to absent BMP9. HHT typically presents with arteriovenous malformations (AVMs) and small vascular malformations called the telangiectases.…”
Section: The Bmp9/bmp10 Pathways In Disease and Their Therapeutic Potmentioning
confidence: 97%
“…Pathogenesis of pulmonary hypertension often involves the abnormal vascular muscularization affecting mainly arterioles, such as the increased proliferation of vascular SMCs (Voelkel, Natarajan et al 2011, Tuder, Archer et al 2013. It has been shown that TGFβ mediated signaling is implicated in the development of pulmonary hypertension, with genetic mutations identified in several genes of this pathway including ALK1, BMPR2, endoglin, BMP9 and the downstream mediators (Goumans, Liu et al 2009, Machado, Southgate et al 2015, Wang, Fan et al 2016. BMPR2 haploinsufficiency was shown to cause pulmonary arterial hypertension (PAH) (Machado, Pauciulo et al 2001), while overexpression of BMPR2 in endothelial cells ameliorated PAH via the suppression of Smad2/3 signaling (Harper, Reynolds et al 2016).…”
Section: Discussionmentioning
confidence: 99%